CPS1 and lung carcinoma: In lung cancer cells, loss of LKB1 and activation of K-RAS led to increased expression of mitochondrial carbamoyl phosphate synthetase-1 (CPS1), increasing the abundance of carbamoyl phosphate intermediates that can exit the mitochondria to be utilized by the de novo pyrimidine synthesis pathways [41].